- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biostem Technologies Inc (BSEM)
Biostem Technologies Inc stock price live, this page displays OTC BSEM stock exchange data. View the BSEM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Biostem Technologies Inc real time stock price chart below.
What Is the Biostem Technologies Inc Stock Price Today?
The Biostem Technologies Inc stock price today is 4.7300.
What Is the Stock Symbol for Biostem Technologies Inc?
The stock symbol for Biostem Technologies Inc is ""BSEM.""
What Stock Exchange Does Biostem Technologies Inc Trade On?
Biostem Technologies Inc is listed and trades on the OTC Markets stock exchange.
Is Biostem Technologies Inc a Good Stock to Buy?
Determining whether Biostem Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BSEM quote. (ISIN: US0906842002)
What Is the Biostem Technologies Inc Stock Price Today?
The Biostem Technologies Inc stock price today is 4.7300.
What Is the Stock Symbol for Biostem Technologies Inc?
The stock symbol for Biostem Technologies Inc is ""BSEM.""
What Stock Exchange Does Biostem Technologies Inc Trade On?
Biostem Technologies Inc is listed and trades on the OTC Markets stock exchange.
Is Biostem Technologies Inc a Good Stock to Buy?
Determining whether Biostem Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BSEM quote. (ISIN: US0906842002)
4.7300
+0.4715(+11.07%)
Closed·
Fair Value
An estimate of a Biostem Tech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.2600
4.7500
52 wk Range
3.0932
19.2800
BSEM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Biostem Tech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.26004.7500
52 wk Range
3.093219.2800
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BSEM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Biostem Tech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Biostem Technologies Inc Company Profile
BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave’s Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.
Biostem Technologies Inc Earnings Call Summary for Q3/2025
- BioStem Technologies reported Q3 2025 EPS of $0.05 (vs $0.28 forecast) and revenue of $10.47M (vs $88.3M forecast), triggering a 10.97% stock price drop to $4.65
- Despite the earnings miss, the company maintained a strong gross margin of 88.5%, though cash balance decreased to $27.2M from $30.8M in Q2 2025
- CEO Jason Matuszewski emphasized BioStem's positioning to capture market share, with plans for a Nasdaq uplisting by mid-2026 and expansion into VA and Medicaid markets
- The company is preparing for a flat-rate Medicare reimbursement model in 2026, while focusing on strategic acquisitions and developing clinical evidence
- Analysts raised concerns about the company's hospital market entry strategy and implications of reimbursement model changes during the earnings call
Last Updated: 13/11/2025, 23:32
Read Full TranscriptCompare BSEM to Peers and Sector
Metrics to compare | BSEM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBSEMPeersSector | |
|---|---|---|---|---|
P/E Ratio | 3.9x | 11.7x | −0.6x | |
PEG Ratio | 0.92 | 0.49 | 0.00 | |
Price/Book | 1.6x | 2.6x | 2.6x | |
Price / LTM Sales | 0.3x | 2.4x | 3.3x | |
Upside (Analyst Target) | - | 89.7% | 39.4% | |
Fair Value Upside | Unlock | 18.5% | 3.9% | Unlock |
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
0.05 / 0.28
Revenue / Forecast
10.47M / 88.30M
People Also Watch
FAQ
What Stock Exchange Does Biostem Tech Trade On?
Biostem Tech is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Biostem Tech?
The stock symbol for Biostem Tech is "BSEM."
What Is the Biostem Tech (BSEM) Afterhours Price Today? (Afterhours variable test: 4.7200) Current Date: 08 Jan 2026
After hours price: 4.7200. After hours price change (units): -0.1100. Price change percentage: -2.2800%
What Is the Biostem Tech Market Cap?
As of today, Biostem Tech market cap is 79.34M.
What Is Biostem Tech's Earnings Per Share (TTM)?
The Biostem Tech EPS (TTM) is 0.85.
When Is the Next Biostem Tech Earnings Date?
Biostem Tech will release its next earnings report on 05 Apr 2026.
From a Technical Analysis Perspective, Is BSEM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Biostem Tech Stock Split?
Biostem Tech has split 5 times.
How Many Employees Does Biostem Tech Have?
Biostem Tech has 33 employees.
What is the current trading status of Biostem Tech (BSEM)?
As of 08 Jan 2026, Biostem Tech (BSEM) is trading at a price of 4.7300, with a previous close of 4.2585. The stock has fluctuated within a day range of 4.2600 to 4.7500, while its 52-week range spans from 3.0932 to 19.2800.
What Is Biostem Tech (BSEM) Price Target According to Analysts?
The average 12-month price target for Biostem Tech is USD25.5, with a high estimate of USD25.5 and a low estimate of USD25.5. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +439.11% Upside potential.
What Is the BSEM After Hours Price?
BSEM's last after hours stock price is 4.7200, the stock has decreased by -0.1100, or -2.2800%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.